Clinical Trial Update: A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension [Phase 4]

View source ↗

Summary

This Phase 4 trial compares GI safety and tolerability of aliskiren versus ramipril in adults with essential hypertension, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Ramipril (ramipril)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-06-21